Onco Therapeutics
年間 4 号発行
ISSN 印刷: 2694-4642
ISSN オンライン: 2694-4650
Indexed in
Immune Complex Analysis in Active Lyme Disease
巻 7,
発行 3-4, 2016,
pp. 213-224
DOI: 10.1615/ForumImmunDisTher.2017019621
要約
Lyme disease (LD) is a growing infectious disease. Assays that can detect active infection early are needed to allow appropriate antibiotic therapy to begin when there is the best chance for a cure. The most frequently used assays are those based on antibodies to Borrelia burgdorferi or its variants, the causative agent of LD. However, an antibody test at a single time point only measures exposure, not necessarily an active infection. In contrast, antibodies that are bound to a target antigen in a circulating immune complex form do indicate active infection. Here, we present data supporting the use of such assays in LD.
619 記事の閲覧数
11 記事のダウンロード
記事の統計
類似内容の記事:
最新号
Preface: Phytochemicals for Colorectal Cancer Therapy
Novel and Latest Computational and Development of Anticancer Cancer
Isoquinoline Alkaloids: Promising Natural Compounds for Targeting Angiogenesis and Metastasis in Colon Cancer
Naringenin in the Prevention of Colon Cancer: An Updated Review
Anti-Cancer Pectins and Their Role in Colorectal Cancer Treatment
Citrus Flavones Luteolin and Apigenin Target Fundamental Mechanisms in Colon Cancer
Dietary Phytocompounds for Colon Cancer Therapy
Nano-Formulation for Curcumin and Resveratrol in Colorectal Cancer Therapy